$20.31
-0.32-1.55%
At close: -
$20.31
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Latest Celldex Therapeutics Stock News | NASDAQ:CLDX | Benzinga
Get the latest news on Celldex Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Celldex Therapeutics performance
Categories: All
Thursday, February 27, 2025
Tuesday, February 18, 2025
Thursday, February 13, 2025
Wednesday, January 29, 2025
Wednesday, January 08, 2025
Thursday, January 02, 2025
Friday, December 20, 2024
Thursday, December 19, 2024
Wednesday, November 20, 2024
Thursday, November 07, 2024
Monday, October 28, 2024
Friday, October 25, 2024
Monday, October 07, 2024
Monday, September 30, 2024
Friday, September 27, 2024
Thursday, September 26, 2024
Wednesday, September 25, 2024
- A Closer Look at 10 Analyst Recommendations For Celldex Therapeutics
- Wolfe Research Reiterates Outperform on Celld...
- Celldex Therapeutics shares are trading lower...
- Celldex Therapeutics Shares Resumed Trade
- Chief Medical Officer Diane C. Young, Of Cell...
- Celldex Therapeutics Reports Safety Concerns ...
- Celldex Therapeutics Presents 52-Week Results...
Friday, September 20, 2024
Wednesday, September 18, 2024
Monday, September 16, 2024
Monday, September 09, 2024
Monday, August 12, 2024
Thursday, August 08, 2024
Tuesday, July 30, 2024
- Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Cantor Fitzgerald Reiterates Overweight on Ce...
- Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- HC Wainwright & Co. Reiterates Buy on Celldex...
- Celldex Therapeutics shares are trading lower...
- Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket